Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

businesswire

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy – NEWSnet – News… as it used to be

More Press Releases

May 3, 2026

BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs

May 3, 2026

Cleveland Kitchen’s Korean Coleslaw Is Bringing K-Beauty’s Skin Secret to the Grocery Aisle

May 3, 2026

Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856

May 3, 2026

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs

Cleveland Kitchen’s Korean Coleslaw Is Bringing K-Beauty’s Skin Secret to the Grocery Aisle

Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856

Senior Fitness Programs Show Measurable Gains in Bone Strength and Balance